Atherectomy Combined with Balloon Angioplasty versus Balloon Angioplasty Alone for de Novo Femoropopliteal Arterial Diseases: A Systematic Review and Meta-analysis of Randomised Controlled Trials
- PMID: 34112574
- DOI: 10.1016/j.ejvs.2021.02.012
Atherectomy Combined with Balloon Angioplasty versus Balloon Angioplasty Alone for de Novo Femoropopliteal Arterial Diseases: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Abstract
Objective: The efficacy and cost effectiveness of atherectomy for femoropopliteal (FP) arterial diseases have not been determined yet. A systematic review and meta-analysis were performed to compare the efficacy and safety between atherectomy combined with balloon angioplasty (BA) and BA alone for patients with de novo FP steno-occlusive lesions.
Methods: The Cochrane Library, Medline, and Embase were used to search for studies evaluating outcomes of atherectomy combined with BA compared with BA alone in FP arterial diseases from inception to July 2020. The methodological quality of the included studies was evaluated with the Cochrane Risk of Bias Tool. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework was used to assess the level of evidence for each outcome. The fixed effects model was chosen to combine the data when I2 < 50%; otherwise, the random effects model was used. Subgroup and sensitivity analyses were performed to further analyse the results.
Results: Four RCTs were included. The meta-analysis showed that atherectomy combined with BA was associated with improved technical success rate (risk ratio [RR] 0.22, 95% confidence interval [CI] 0.13-0.38, p < .001; I2 = 0; high quality), reduced bailout stenting (RR 0.15, 95% CI 0.07-0.32, p < .001; I2 = 16%; high quality), and flow limiting dissection (RR 0.24, 95% CI 0.13-0.47, p < .001; I2 = 0; high quality). No statistically significant difference was found in target lesion revascularisation (TLR), primary patency, mortality, major adverse event (MAE), or ankle brachial index (ABI) after one year follow up.
Conclusion: Compared with BA alone, atherectomy combined with BA may not improve primary patency, TLR, mortality rate, or ABI, but may reduce the need for bailout stenting and the incidence of flow limiting dissection and increase the technical success rate in FP arterial diseases. More studies are warranted to further confirm the conclusion.
Keywords: Angioplasty; Atherectomy; Femoropopliteal artery; Meta-analysis; Peripheral artery disease; Systematic review.
Copyright © 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Systematic Review and Network Meta-analysis of Vessel Preparation Techniques With Plain Balloon Angioplasty, Atherectomy, or Intravascular Lithotripsy Before Application of a Drug Coated Balloon to Treat Atherosclerotic Femoropopliteal Disease.Eur J Vasc Endovasc Surg. 2025 Jan;69(1):118-129. doi: 10.1016/j.ejvs.2024.08.002. Epub 2024 Aug 8. Eur J Vasc Endovasc Surg. 2025. PMID: 39121903
-
Atherectomy for peripheral arterial disease.Cochrane Database Syst Rev. 2020 Sep 29;9(9):CD006680. doi: 10.1002/14651858.CD006680.pub3. Cochrane Database Syst Rev. 2020. PMID: 32990327 Free PMC article.
-
Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials.J Cardiovasc Surg (Torino). 2014 Oct;55(5):655-65. Epub 2014 Jul 10. J Cardiovasc Surg (Torino). 2014. PMID: 25008063
-
Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):92-101. doi: 10.1016/j.jcin.2014.09.009. Epub 2014 Dec 10. JACC Cardiovasc Interv. 2015. PMID: 25499305 Clinical Trial.
-
Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis.Vascular. 2021 Dec;29(6):883-896. doi: 10.1177/1708538120985732. Epub 2021 Jan 21. Vascular. 2021. PMID: 33478353
Cited by
-
Safety and Feasibility of the BYCROSS® Atherectomy Device for the Treatment of Femoropopliteal Arterial Obstructions: Single-Center Short-Term Outcomes.J Clin Med. 2024 Mar 21;13(6):1809. doi: 10.3390/jcm13061809. J Clin Med. 2024. PMID: 38542032 Free PMC article.
-
Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion.Sci Rep. 2024 Jan 2;14(1):63. doi: 10.1038/s41598-023-50511-8. Sci Rep. 2024. PMID: 38167567 Free PMC article.
-
Use of Rotational Atherectomy-Assisted Balloon Angioplasty in the Treatment of Isolated Below-the-Knee Atherosclerotic Lesions in Patients with Chronic Limb-Threatening Ischemia.J Clin Med. 2024 Feb 27;13(5):1346. doi: 10.3390/jcm13051346. J Clin Med. 2024. PMID: 38592186 Free PMC article.
-
Jetstream Atherectomy with Paclitaxel-Coated Balloons: 3-Year Outcomes of the Prospective Randomized JET-RANGER Study.Int J Angiol. 2024 Oct 3;34(1):56-59. doi: 10.1055/s-0044-1791546. eCollection 2025 Mar. Int J Angiol. 2024. PMID: 39944148
-
Trends and Factors Associated With Peripheral Vascular Interventions for the Treatment of Claudication From 2011 to 2022: A National Medicare Cohort Study.J Am Heart Assoc. 2024 Jul 16;13(14):e033463. doi: 10.1161/JAHA.123.033463. Epub 2024 Jul 3. J Am Heart Assoc. 2024. PMID: 38958132 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical